sec.236Matters to be considered before making particular extended practice authorities— Act , s 232

sec.236 Matters to be considered before making particular extended practice authorities— Act , s 232

For section 232 (3) of the Act , the following matters are prescribed in relation to a dealing with a medicine— the nature of the dealing; whether there is a community need for any service to be facilitated by the extended practice authority; the way in which any health risks associated with the dealing are to be managed under the authority; whether there is a need for a review of the authority and the timing of any review needed; if the approved person is subject to the governance of an entity under the authority—the governance capability of the entity; if the medicine is a restricted medicine or unregistered medicine—whether it is in the public interest to make the authority, considering the particular health risks associated with restricted medicines and unregistered medicines. In this section— unregistered medicine means a medicine that is not included in a product on the Australian Register of Therapeutic Goods. s 236 amd 2024 SL No. 102 s 5 (sec.236-ssec.1) For section 232 (3) of the Act , the following matters are prescribed in relation to a dealing with a medicine— the nature of the dealing; whether there is a community need for any service to be facilitated by the extended practice authority; the way in which any health risks associated with the dealing are to be managed under the authority; whether there is a need for a review of the authority and the timing of any review needed; if the approved person is subject to the governance of an entity under the authority—the governance capability of the entity; if the medicine is a restricted medicine or unregistered medicine—whether it is in the public interest to make the authority, considering the particular health risks associated with restricted medicines and unregistered medicines. (sec.236-ssec.2) In this section— unregistered medicine means a medicine that is not included in a product on the Australian Register of Therapeutic Goods.

• (a) the nature of the dealing;
• (b) whether there is a community need for any service to be facilitated by the extended practice authority;
• (c) the way in which any health risks associated with the dealing are to be managed under the authority;
• (d) whether there is a need for a review of the authority and the timing of any review needed;
• (e) if the approved person is subject to the governance of an entity under the authority—the governance capability of the entity;
• (f) if the medicine is a restricted medicine or unregistered medicine—whether it is in the public interest to make the authority, considering the particular health risks associated with restricted medicines and unregistered medicines.